Article, COVID-19 Vaccine, Licensing and World Health

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Article

COVID-19 Vaccine

Licensing

World Health

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

Bill of Health

MARCH 24, 2022

At the research and development (R&D) stage, government funders can bind producers to equity goals through targeted contractual provisions, as we explain in a recently-published Nature Biotechnology article. Consider, for instance, the case of COVID-19 vaccines. The second pathway is that of a dormant license.

COVID-19 Vaccine

COVID-19 Vaccine Licensing COVID-19 Public Health

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

AUGUST 29, 2022

Monsanto and Myriad) ( this 2015 article discusses the history and taxonomy of patent pledges, many of which are collected in this online database ). The unprecedented scope of the COVID-19 pandemic quickly gave rise to a surge of pledging activity, which is detailed in this article (see pp. Pandemic Pledges.

COVID-19 Vaccine

COVID-19 Vaccine COVID-19 Licensing Governance

Health Care Compliance Brief

Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Stay Connected